An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major

BACKGROUND: Protozoan parasites from the genus Leishmania cause broad clinical manifestations known as leishmaniases, which affect millions of people worldwide. Cutaneous leishmaniasis (CL), caused by L. major, is one the most common forms of the disease in the Old World. There is no preventive or t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS Negl Trop Dis
Autors principals: Iniguez, Eva, Schocker, Nathaniel S., Subramaniam, Krishanthi, Portillo, Susana, Montoya, Alba L., Al-Salem, Waleed S., Torres, Caresse L., Rodriguez, Felipe, Moreira, Otacilio C., Acosta-Serrano, Alvaro, Michael, Katja, Almeida, Igor C., Maldonado, Rosa A.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673233/
https://ncbi.nlm.nih.gov/pubmed/29069089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006039
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars